CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 89 filers reported holding CHEMOCENTRYX INC in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $21,381,000 | +91.2% | 413,863 | -8.3% | 0.01% | +100.0% |
| Q2 2022 | $11,180,000 | -30.6% | 451,151 | -29.8% | 0.00% | 0.0% |
| Q1 2022 | $16,119,000 | -73.5% | 642,949 | -61.5% | 0.00% | +50.0% |
| Q4 2021 | $60,822,000 | +188.9% | 1,670,492 | +35.7% | 0.00% | -33.3% |
| Q3 2021 | $21,051,000 | +18.0% | 1,231,074 | -7.6% | 0.00% | 0.0% |
| Q2 2021 | $17,847,000 | +696.7% | 1,332,870 | +2948.4% | 0.00% | – |
| Q1 2021 | $2,240,000 | -94.1% | 43,723 | -92.9% | 0.00% | -100.0% |
| Q4 2020 | $38,168,000 | +58.3% | 616,430 | +40.1% | 0.00% | -25.0% |
| Q3 2020 | $24,111,000 | -36.0% | 439,987 | -32.8% | 0.00% | -55.6% |
| Q2 2020 | $37,698,000 | +30.9% | 655,168 | -8.6% | 0.01% | -10.0% |
| Q1 2020 | $28,794,000 | +26.7% | 716,619 | +24.7% | 0.01% | +42.9% |
| Q4 2019 | $22,720,000 | +464.9% | 574,473 | -3.1% | 0.01% | +250.0% |
| Q3 2019 | $4,022,000 | -52.3% | 593,094 | -34.5% | 0.00% | +100.0% |
| Q2 2019 | $8,424,000 | +178.0% | 905,805 | +315.3% | 0.00% | -50.0% |
| Q1 2019 | $3,030,000 | +56.5% | 218,100 | +22.9% | 0.00% | – |
| Q4 2018 | $1,936,000 | -12.3% | 177,447 | +1.6% | 0.00% | – |
| Q3 2018 | $2,208,000 | +112.1% | 174,700 | +121.0% | 0.00% | – |
| Q2 2018 | $1,041,000 | +208.9% | 79,053 | +218.8% | 0.00% | – |
| Q1 2018 | $337,000 | -10.4% | 24,800 | -51.2% | 0.00% | – |
| Q4 2016 | $376,000 | +251.4% | 50,774 | +186.9% | 0.00% | – |
| Q3 2016 | $107,000 | -61.5% | 17,700 | -71.5% | 0.00% | – |
| Q2 2016 | $278,000 | +21.9% | 62,052 | +120.8% | 0.00% | – |
| Q4 2015 | $228,000 | 0.0% | 28,100 | -25.5% | 0.00% | – |
| Q3 2015 | $228,000 | -78.6% | 37,700 | -70.8% | 0.00% | – |
| Q2 2015 | $1,064,000 | +132.3% | 129,322 | +113.4% | 0.00% | – |
| Q1 2015 | $458,000 | -25.5% | 60,600 | -32.7% | 0.00% | – |
| Q4 2014 | $615,000 | +204.5% | 90,059 | +100.5% | 0.00% | – |
| Q3 2014 | $202,000 | -73.4% | 44,919 | -65.4% | 0.00% | – |
| Q2 2014 | $758,000 | +30.0% | 129,651 | +47.3% | 0.00% | – |
| Q1 2014 | $583,000 | -47.8% | 87,994 | -54.4% | 0.00% | – |
| Q4 2013 | $1,116,000 | +32.4% | 192,830 | +27.3% | 0.00% | – |
| Q3 2013 | $843,000 | – | 151,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |